ArticleAmerican journal of public health2018
Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients.
Article in American journal of public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Identifying gaps in women's preventive health services for women living with HIV in Vermont.Reproductive health · 2025Article
- Pediatric vaccination in pharmacies is not associated with delayed well-child visits among commercially insured children.Health affairs scholar · 2025Article
- HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US.Human vaccines & immunotherapeutics · 2023Article
- Integrated Health Maintenance Reminders for Improved HPV Vaccine Administration: Toward Improvements in Completion Disparities.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2023Article
- Social determinants of human papillomavirus vaccine series completion among U.S. adolescents: A mixed-methods study.SSM - population health · 2022Article
- Association of Maternal Cervical Disease With Human Papillomavirus Vaccination Among Offspring.JAMA network open · 2021Article
- Factors Associated With Human Papillomavirus Vaccine Series Completion Among Adolescents.American journal of preventive medicine · 2021Article
- Factors associated with HPV vaccination initiation among United States college students.Human vaccines & immunotherapeutics · 2021Article
- Associations between insurance-related affordable care act policy changes with HPV vaccine completion.BMC public health · 2021Article
- An educational intervention to improve attitudes regarding HPV vaccination and comfort with counseling among US medical students.Human vaccines & immunotherapeutics · 2020Article
- Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine.Frontiers in immunology · 2020Review
- Predictors of Human Papillomavirus Vaccine Completion Among Low-Income Latina/o Adolescents.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2019Article
- Article
- Review
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
Abstract
objectivesTo assess predictors of timely human papillomavirus (HPV) vaccine follow-through among privately insured individuals initiating the 3-dose series.
methodsUsing MarketScan Commercial claims data, we identified 1 332 217 privately insured US individuals aged 9 to 26 years who initiated the bivalent or quadrivalent HPV vaccine series from 2006 to 2014, with follow-up data extending through 2015. The study outcome was receipt of third HPV dose within 12 months of the first, compared by year of initiation. Control variables were age, region, insurance plan type, provider type, and seasonal influenza vaccination.
resultsTimely HPV vaccine follow-through fell over time. The trend was especially pronounced for females (from 67% in 2006 to 38% in 2014), but was also present for males (from 36% in 2011 to 33% in 2014). Similar patterns were present when we controlled for patient and provider characteristics or used alternative definitions of follow-through. Other positive predictors of timely follow-through included receipt of flu vaccine in the prior year and receipt of first HPV vaccine dose from an obstetrician/gynecologist.
conclusionsHPV vaccine follow-through is low and has declined over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.